The prevalence of heart failure is increasing as the demographic profile of the American population gets older.
The prevalence of heart failure is increasing as the demographic profile of the American population gets older.
An estimated 6.2 million American adults, age 20 and older, had heart failure between 2013 and 2016, compared with an estimated 5.7 million between 2009 and 2012.
Of incident hospitalized heart failure events, approximately half are characterized by reduced ejection fraction and half by preserved ejection fraction.
The prevalence of heart failure with preserved ejection fraction, compared with prevalence of heart failure with reduced ejection fraction, appears to be increasing along with aging of the population.
CMS Coverage Decision of Pulmonary Embolectomy Criticized
November 19th 2021JAMA Internal Medicine editor and a UCSF colleague wrote in a New England Journ of Medicine opinion piece that the decision highlights the need to establish a new requirement that would make coverage decisions contingent on evidence of benefit for Medicare population.
Read More
FDA Updates: Genentech Withdraws Tecentriq Indication; New Approvals for Xarelto, Tibsovo
August 28th 2021Tecentriq loses indication, Xarelto is approved for reduce risks of cardiovascular events, Tibsovo is approved for rare cancer, Skytrofa is a new, once-weekly growth hormone, and supplemental application is filed Orencia graft-versus-host disease.
Read More
FDA Updates: Opdivo, Jardiance and Jemperli Get Nods for New Indications
August 21st 2021FDA approves Opdivo, Jardiance for new indication, Jemperli gets accelerated approval for solid tumors, and Lilly’s rapid-acting insulin, Lyumjev is approved for administration via an insulin pump.
Read More